Iolyx Therapeutics
PrivateLast Round
Series B
Dec 3, 2025
Total Funding Raised
$45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Iolyx Therapeutics operates in Healthcare & Life Sciences and is based in Burlingame, California. Its latest recorded funding round was a Series B round in December 2025.
Iolyx Therapeutics is a biotechnology company that develops targeted immunomodulatory therapies for ocular inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iolyx Therapeutics Comparables
Compare Iolyx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stuart Therapeutics, Inc. | 87% | |
| TearSolutions | 87% | |
| Selagine, Inc. | 83% |
For institutional investors. Book with your work email.
Iolyx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 3, 2025 | ||||
| Series A | Apr 20, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iolyx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series A |
| Frazier Life Sciences | Series B |
| Cooley | Series B |
| Alumni Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 68% MoM.
- Dec 3, 2025
$15M round completed.
For institutional investors. Book with your work email.
Iolyx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iolyx Therapeutics's valuation, stock price, and market status.
Is Iolyx Therapeutics a public or private company?
Iolyx Therapeutics is a private company.
What is the current stock price of Iolyx Therapeutics?
Iolyx Therapeutics is a private company, so its shares have no public market price. Caplight tracks Iolyx Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iolyx Therapeutics worth (valuation)?
Valuation information for Iolyx Therapeutics is not publicly available.
Can I buy Iolyx Therapeutics stock?
Iolyx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iolyx Therapeutics's last funding round?
Iolyx Therapeutics's most recent funding round was Series B on December 3, 2025.
Who are the main investors in Iolyx Therapeutics?
Key investors in Iolyx Therapeutics include Frazier Life Sciences.
Will Iolyx Therapeutics IPO soon?
No public IPO plans have been announced for Iolyx Therapeutics.
How can I track Iolyx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Iolyx Therapeutics's shares on secondary markets.